Yagi & Co.,Ltd.
Yagi & Co.,Ltd. (7460.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Yagi & Co.,Ltd. (7460.T), featuring income statements, balance sheets, and cash flow data.
Yagi & Co.,Ltd. (7460.T) Income Statement & Financial Overview
Review Yagi & Co.,Ltd. 7460.T income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $21.73B | $22.34B | $19.36B | $19.94B |
| Cost of Revenue | $14.76B | $15.14B | $14.42B | $14.91B |
| Gross Profit | $6.97B | $7.20B | $4.94B | $5.03B |
| Gross Profit Ratio | $0.32 | $0.32 | $0.26 | $0.25 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $6.12B | $5.57B | $4.52B | $4.36B |
| Operating Expenses | $6.12B | $5.57B | $4.52B | $4.36B |
| Total Costs & Expenses | $20.88B | $20.71B | $18.94B | $19.27B |
| Interest Income | $19.00M | $9.00M | $12.00M | $5.00M |
| Interest Expense | $13.00M | $15.00M | $14.00M | $8.00M |
| Depreciation & Amortization | $175.00M | $180.00M | $181.00M | $180.00M |
| EBITDA | $1.09B | $1.81B | $598.00M | $956.00M |
| EBITDA Ratio | $0.05 | $0.08 | $0.03 | $0.05 |
| Operating Income | $851.00M | $1.63B | $419.00M | $671.00M |
| Operating Income Ratio | $0.04 | $0.07 | $0.02 | $0.03 |
| Other Income/Expenses (Net) | $51.00M | $137.00M | $41.00M | $99.00M |
| Income Before Tax | $902.00M | $1.77B | $460.00M | $771.00M |
| Income Before Tax Ratio | $0.04 | $0.08 | $0.02 | $0.04 |
| Income Tax Expense | $229.00M | $529.00M | $228.00M | $288.00M |
| Net Income | $672.00M | $1.24B | $232.00M | $482.00M |
| Net Income Ratio | $0.03 | $0.06 | $0.01 | $0.02 |
| EPS | $80.17 | $147.83 | $27.75 | $57.81 |
| Diluted EPS | $80.17 | $147.83 | $27.75 | $57.81 |
| Weighted Avg Shares Outstanding | $8.38M | $8.38M | $8.36M | $8.34M |
| Weighted Avg Shares Outstanding (Diluted) | $8.38M | $8.38M | $8.36M | $8.34M |
Over the past four quarters, Yagi & Co.,Ltd. demonstrated steady revenue growth, increasing from $19.94B in Q1 2024 to $21.73B in Q4 2024. Operating income reached $851.00M in Q4 2024, maintaining a consistent 4% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.09B, reflecting operational efficiency. Net income dropped to $672.00M, with EPS at $80.17. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan